CRISPR TEXNOLOGIYASINING COVID-19 DIAGNOSTIKASI VA TERAPIYASIDAGI ZAMONAVIY IMKONIYATLARI

Authors

  • Abdurahmonova K.R. TDTU Mikrobiologiya, virusologiya immunologiya kafedrasi assistenti
  • O‘sarova M.U. TDTU 1- Davolash fakulteti talabasi
  • Eshmuminova M.N. TDTU 1-Davolash fakulteti talabasi
  • Hamidova B.G‘. TDTU 1-Davolash fakulteti talabasi

Keywords:

CRISPR, COVID-19, SARS-CoV-2, gen tahrirlash, Cas9, Cas13, molekulyar diagnostika, biotexnologiya.

Abstract

Ushbu maqolada CRISPR texnologiyasining COVID-19 ni aniqlash va davolashdagi zamonaviy imkoniyatlari o‘rganildi. CRISPR tizimining molekulyar-biologik asoslari, Cas oqsillari ishtirokidagi mexanizmlari hamda uning diagnostik va terapevtik yo‘nalishlardagi qo‘llanilishi tahlil qilindi. Tadqiqot natijalariga ko‘ra, CRISPR asosidagi usullar yuqori aniqlik va tezkorlikka ega bo‘lib, ayniqsa virusni aniqlashda istiqbolli hisoblanadi. Biroq uning klinik amaliyotga keng joriy etilishi uchun qo‘shimcha xavfsizlik va samaradorlik tadqiqotlari talab etiladi.

References

Abbott T.R. et al. (2020). Development of CRISPR as an antiviral strategy to combat SARS-CoV-2 and influenza. Cell.

Abudayyeh O.O. et al. (2016). C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science.

Barrangou R. et al. (2007). CRISPR provides acquired resistance against viruses in prokaryotes. Science.

Barrangou R., Doudna J.A. (2016). Applications of CRISPR technologies in research and beyond. Nature Biotechnology

Broughton J.P. et al. (2020). CRISPR–Cas12-based detection of SARS-CoV-2. Nature Biotechnology.

Chen J.S. et al. (2018). CRISPR-Cas12a target binding unleashes indiscriminate ssDNA cleavage activity. Science.

Corman V.M. et al. (2020). Detection of 2019 novel coronavirus (SARS-CoV-2) by RT-PCR. Euro Surveillance.

Doudna J.A., Charpentier E. (2014). The new frontier of genome engineering with CRISPR-Cas9. Science.

Fozouni P. et al. (2021). Direct detection of SARS-CoV-2 using CRISPR-Cas13. Cell.

Gootenberg J.S. et al. (2017). Nucleic acid detection with CRISPR-Cas13. Science.

Hoffmann M. et al. (2020). SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2. Cell.

Horvath P., Barrangou R. (2010). CRISPR/Cas, the immune system of bacteria and archaea. Science.

Hsu P.D. et al. (2013). DNA targeting specificity of RNA-guided Cas9 nucleases. Nature Biotechnology.

Hsu P.D. et al. (2014). Development and applications of CRISPR-Cas9 for genome engineering. Cell.

Jinek M. et al. (2012). A programmable dual-RNA–guided DNA endonuclease in adaptive bacterial immunity. Science.

Kellner M.J. et al. (2019). SHERLOCK: nucleic acid detection with CRISPR. Nature Protocols.

Ledford H. (2020). CRISPR treatment inserted directly into the body for first time. Nature.

Lino C.A. et al. (2018). Delivery of CRISPR/Cas9 for therapeutic applications. Drug Delivery.

Marraffini L.A. (2015). CRISPR-Cas immunity in prokaryotes. Nature.

Marraffini L.A., Sontheimer E.J. (2008). CRISPR interference limits horizontal gene transfer in bacteria. Science.

World Health Organization (WHO). (2020). Diagnostic testing for SARS-CoV-2.

World Health Organization (WHO). (2022). Global excess deaths associated with COVID-19 pandemic.

Worldometer. (2026). COVID-19 Coronavirus Pandemic Data. Available at: https://www.worldometers.info/coronavirus/⁠

Downloads

Published

2026-05-20